Avocado Consumption and Cellular Aging in Breast Cancer Survivors

Recruiting N/A Interventional Study
Telomere Length Breast Cancer Females
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 65
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
120 (estimated)
Sponsor
Institut Investigacio Sanitaria Pere Virgili · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Women with breast cancer are at increased risk of comorbidities and premature mortality, potentially due to accelerated biological aging. Telomere attrition has been proposed as a biomarker of this process, which could be mitigated through interventions targeting behavioral factors such as diet. In recent years, avocado has drawn attention in nutritional research due to its unique nutritional prof…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women diagnosed with primary breast cancer in stages I, II or III; * 40-65 years old at screening; * Cancer treatment (radiotherapy and chemotherapy) completed ≥ 6 months but not more than 10 years at the time of recruitment; * Currently consuming less than 2 avocados per week…
Contacts

Nerea Becerra Tomás, PhD

+34977759334

nerea.becerra@urv.cat

CONTACT

Victoria Arija, Professor

+34977759334

victoria.arija@urv.cat

CONTACT